Literature DB >> 29743908

Quantitative estimation of aortic valve calcification in multislice computed tomography in predicting the development of paravalvular leaks following transcatheter aortic valve replacement.

Małgorzata Ryś1, Tomasz Hryniewiecki1, Ilona Michałowska2, Patrycjusz Stokłosa1, Monika Różewicz-Juraszek1, Zbigniew Chmielak3, Maciej Dąbrowski3, Kryspin Mirota4, Piotr Szymański1.   

Abstract

INTRODUCTION: Transcatheter aortic valve implantation (TAVI) improves prognosis in patients disqualified from surgical valve replacement. Calcifications of the aortic complex can lead to deformation of the prosthesis, resulting in paravalvular leaks (PVL). AIM: To evaluate the predictive value of quantitative estimation of volume/weight and geometric distribution of calcifications in multislice computed tomography, for the development of PVL.
MATERIAL AND METHODS: This was a retrospective, case-control study on patients with a CoreValve aortic prosthesis. The study group consisted of 20 patients with confirmed significant PVL after TAVI. The control group consisted of 20 patients without significant PVL, matched according to valve type and clinical characteristics. The size spatial distribution and shape of calcifications were measured.
RESULTS: The average age of patients was 79.9 years (60% women). Cases and controls did not differ in their clinical characteristics. The size of the aortic annulus was significantly larger in cases vs. controls (23.4 ±1.6 vs. 22 ±1.4 mm, p = 0.01). Volume, area and curvature of calcifications were greater in cases vs controls (1.09 ±0.56 vs. 0.59 ±0.41 cm3, p = 0.011; 15.26 ±5.46 vs. 9.50 ±5.29 cm2, p = 0.008; 1.76 ±0.07 vs. 1.68 ±0.13 cm3, p = 0.037). In multivariate analysis, adjusted for aortic annulus size, the area of aortic valve calcifications independently predicted paravalvular regurgitation (OR = 1.41, 95% CI: 0.09-1.92, p < 0.009).
CONCLUSIONS: Morphometric analysis of aortic valve calcifications predicted the risk of paravalvular leak following TAVI irrespectively of patients' clinical characteristics.

Entities:  

Keywords:  aortic regurgitation; aortic stenosis; transcatheter aortic valve implantation

Year:  2018        PMID: 29743908      PMCID: PMC5939549          DOI: 10.5114/aic.2018.74359

Source DB:  PubMed          Journal:  Postepy Kardiol Interwencyjnej        ISSN: 1734-9338            Impact factor:   1.426


Introduction

Transcatheter aortic valve implantation (TAVI) improves prognosis in patients who are disqualified from surgical replacement of the valve and also high-risk patients whose transcutaneous interventions are an alternative to classical surgery [1-3]. The procedure of implantation involves active and passive expansion of the prosthesis in the aortic valve. The degree and nature of aortic root calcifications is one of the factors affecting the outcome of the intervention [4]. Severe, asymmetric calcifications can lead to deformation of the prosthesis, resulting in paravalvular leaks in a few to dozens or so percent of patients [5, 6]. The severity of calcification of the aortic complex seems to be related also to the risk of its periprocedural rupture [7]. Paravalvular leaks may also be caused by valve dislocation and undersizing of the prosthesis [8, 9]. Aortic root calcification was usually assessed either qualitatively or semi-quantitatively, based on subjective scales of echocardiographic criteria and/or Agatston scoring. In most cases geometric distribution of calcifications was not assessed or assessed only semi-quantitatively [10-12]. The geometry of calcifications however seems to be crucial to the success of the intervention, based on the experience gathered in patients with bicuspid aortic valves [13, 14].

Aim

The aim of the current study was to evaluate the possibility of using the quantitative estimation of volume/weight and geometric distribution of calcification in multi-slice computed tomography (MSCT) in predicting the development of paravalvular leaks following TAVI.

Material and methods

Study group

This was a case-control study on a retrospectively selected group of patients with a percutaneously implanted CoreValve aortic prosthesis. The study group consisted of 20 patients with echocardiographically confirmed significant paravalvular leak after TAVI, defined as at least moderate aortic regurgitation. The control group consisted of 20 patients, matched according to their clinical characteristics, without significant paravalvular leak following CoreValve implantation.

Multi-slice computed tomography (MSCT)

Before TAVI, all patients had had an MSCT examination evaluating the atherosclerotic deposits of the aortic valve. Non-contrast and contrast ECG-gated computed tomography examinations were performed with a dual source scanner (Somatom Definition Flash, Siemens Medical Solutions) with beam collimation of 64 × 0.6 mm, 128 slices, a gantry rotation time of 280 ms, and tube voltage 100–120 kV depending on the patient’s body mass. The scan of the heart ranged from the carina to the heart base. The patients did not receive any medicine regardless of the heart rate. Morphometric assessment of calcifications was carried out in three aspects: the volume, area and curvature of calcifications (Figure 1). The starting point for evaluation was the spatial reconstruction of the surface edge using the marching cubes algorithm.
Figure 1

Exemplary reconstruction of aortic valve calcifications. Calcifications located in the aortic valve cusps. There is a variety of calcifications – asymmetric calcifications are visible on the right side and symmetrical distribution on the left side

Exemplary reconstruction of aortic valve calcifications. Calcifications located in the aortic valve cusps. There is a variety of calcifications – asymmetric calcifications are visible on the right side and symmetrical distribution on the left side

Echocardiography

The degree of paravalvular leak (which is the criterion for assigning the patient to either the study or control group) was assessed on the basis of a routine transthoracic echocardiographic study performed after TAVI during that hospitalization. The degree of valvular regurgitation was defined according to the Valve Academic Research Consortium (VARC-2) [15]. The residual aortic regurgitation (in the form of paravalvular leak) was classified as: trivial-to-mild (≤ 2 + on a semi-quantitative scale) or moderate-to-severe (> 2+ on a semi-quantitative scale).

Statistical analysis

The groups were characterized by descriptive statistics. Continuous data were expressed as mean ± standard deviation (± SD), or median and range of values, depending on the distribution, and categorical variables as numbers/percentages (%). Case and control groups were compared using Student’s t-test or Mann-Whitney tests in the case of continuous values with normal and skewed distributions respectively, and discrete variables using the χ2 test. Uni- and multivariate logistic regression (adjusting for aortic annulus size) was used to assess the predictive value of aortic valve calcification in the prediction of paravalvular regurgitation. A value of p < 0.05 was considered to be statistically significant.

Results

The average age of the studied patients was 79.9 years (62–92 years). Sixty percent of the patients were women (24 women, 16 men). Baseline clinical characteristics of cases and controls is presented in Table I. There were no significant differences between groups in the clinical characteristics of patients.
Table I

Demographic, clinical and laboratory characteristics of patients

ParameterStudy group (n = 20)Control group (n = 20) P-value
Age [years]80.5 ±5.679.3 ±7.210.56
Sex (men)8 (20%)8 (20%)1.00
Logistic EuroSCORE (%)22.6 ±8.620.8 ±11.30.56
Hypertension17 (42.5%)15 (37.5%)0.42
NYHA functional class III19 (47.5%)19 (47.5%)1.00
NYHA functional class IV1 (2.5%)1 (2.5%)1.00
Creatinine [mg/dl]120.5 ±72.5103.8 ±30.20.34
eGFR [ml/min]50.3 ±15.954.3 ±14.30.41
Diabetes mellitus5 (12.5%)7 (17.5%)0.54
Coronary artery disease16 (40%)18 (45%)0.65

Data are presented as the number (%) of patients or mean value ± SD. eGFR – estimated glomerular filtration rate, EuroSCORE – European system for cardiac operative risk evaluation, NYHA – New York Heart Association.

Demographic, clinical and laboratory characteristics of patients Data are presented as the number (%) of patients or mean value ± SD. eGFR – estimated glomerular filtration rate, EuroSCORE – European system for cardiac operative risk evaluation, NYHA – New York Heart Association. Echocardiographic data in cases and control groups are summarized in Table II. A significant difference was noted in the size of the aortic annulus. The frequency and severity of pre-procedural aortic regurgitation were not significantly different between cases and controls. There were significant differences between cases and controls in the volume (1.09 ±0.56 vs. 0.59 ±0.41 cm3, p = 0.011), area (15.26 ±5.46 vs. 9.50 ±5.29 cm2, p = 0.008), and curvature (1.76 ±0.07 vs. 1.68 ±0.13 cm3, p = 0.037) of the calcifications (Figure 2). Significant predictors of paravalvular aortic regurgitation following TAVI in univariate analysis are presented in Table III. In multivariate analysis, adjusted for aortic annulus size, the area of aortic valve calcifications independently predicted paravalvular regurgitation (OR = 1.41, 95% CI: 0.09–1.92, p < 0.009).
Table II

Comparison of echocardiographic findings in cases and controls

ParameterStudy group (n = 20)Control group (n = 20) P-value
LVDD [mm]51.3 ±8.646.7 ±7.40.06
IVS [mm]15.7 ±2.215.6 ±2.20.79
LVOT [mm]21.0 ±2.319.6 ±1.80.10
Aortic annulus TTE [mm]23.4 ±1.622 ±1.40.01
Aortic root [mm]35.2 ±4.232.6 ±1.90.08
AoGradMax [mm Hg]100.0 ±27.397.6 ±22.80.76
AoGradMean [mm Hg]62.1 ±1660.9 ±170.96
AVA [cm2]0.66 ±0.080.61 ±0.140.31
EF (%)53.05 ±14.357.2 ±130.34

Data are presented as the number (%) of patients or mean value ± SD. AVA – aortic valve area, AoGradMax – maximum aortic gradient, AoGradMean – mean aortic gradient, EF – ejection fraction, IVS – interventricular septum, LVDD – left ventricular diastolic diameter, LVOT – left ventricular outflow tract, TTE – transthoracic echocardiography.

Figure 2

Aortic valve calcifications in cases and controls. A – Volume of calcifications, B – area of calcification, C – curvature of calcification

Table III

Results of univariate modeling of variables predictive of paravalvular leak after TAVI

ParameterOdds ratio95% Confidence interval P-value
Volume [cm3]9.032< 1.658; 49.203>0.011
Area/magnitude [cm2]1.227<1.056; 1.425>0.008
Curvature of calcification [cm3]5412.958<1.711; 17120823.307>0.037
Aortic annulus [mm]1.833<1.074; 3.130>0.026
Comparison of echocardiographic findings in cases and controls Data are presented as the number (%) of patients or mean value ± SD. AVA – aortic valve area, AoGradMax – maximum aortic gradient, AoGradMean – mean aortic gradient, EF – ejection fraction, IVS – interventricular septum, LVDD – left ventricular diastolic diameter, LVOT – left ventricular outflow tract, TTE – transthoracic echocardiography. Results of univariate modeling of variables predictive of paravalvular leak after TAVI Aortic valve calcifications in cases and controls. A – Volume of calcifications, B – area of calcification, C – curvature of calcification

Discussion

This was a case-control hypothesis generating study that aimed to assess whether quantitative geometric analysis of aortic valve calcifications is able to predict paravalvular leak following TAVI. Both the cases and controls had a CoreValve prosthesis implanted in the aortic position and their clinical characteristics were well matched and adjusted. The clinical characteristics of the patients did not differ from those described in other series of TAVI patients [16]. The only statistically significant difference noted was the size of the aortic annulus – which was larger in case patients than in control ones. Aortic root diameter (at the sinus of Valsalva) and left ventricular outflow tract (LVOT) diameter were insignificantly larger in cases than in controls. Because the association between the occurrence of paravalvular leak and aortic annulus was expected, we adjusted for this difference in multivariate analysis, in which it did not prove to be an independent predictor of paravalvular leak. It must be mentioned that the influence of aortic annulus on the risk of paravalvular leak may be compensated by the choice of the correct valve size and valve expansion (in the case of balloon-expandable prostheses), as other authors have previously stated in their studies. For example, Unbehaun et al. demonstrated in multivariate analysis that NYHA class IV, male sex, and absence of prior aortic valve surgery were responsible for the presence of paravalvular leak [17]. In our series we did not observe differences in the clinical characteristics between the study and control group. This may be explained by the case-control settings that we used and small sample size of our series. Until now, several attempts have been made to assess the relationship between calcifications of the aortic complex (assessed in the MSCT) and the presence of paravalvular leak. Haensig et al. evaluated 120 patients treated by TAVI using scoring analogous to the Agatston calcium scoring of coronary arteries (Aortic Valve Calcium Scoring (AVCS)) in MSCT. Paravalvular leak was assessed in echocardiography and angiography. Increasing AVCS was associated with a significantly higher risk of paravalvular leak [18]. Similarly, Ewe et al. described a set of 79 patients undergoing TAVI, qualitatively evaluating the volume of calcification in MSCT and its localization. A significant relationship between calcification characteristics and significant aortic regurgitation was reported [19]. In the analysis of 100 patients who received a CoreValve during TAVI, John et al. [10] demonstrated a significant correlation between the presence of atherosclerotic deposits of the aortic complex and the presence of paravalvular leak. As in the above-mentioned article, Schultz et al. [20], Vahanian et al. [21] and Khalique et al. [22] described the relationship between the presence of atherosclerotic deposits and significant aortic valve regurgitation after TAVI. In contrast, Wood et al. [23] did not observe any correlation between the presence of leak after TAVI and the degree of calcification of the aortic valve, which was most likely related to the small group of patients included in the analysis (n = 26). A new self-expandable valve was introduced recently to reduce the incidence of paravalvular leaks. It is equipped with an outer wrap intended to enhance contact between the valve and the native aortic annulus. Limited data presented recently at the American College of Cardiology Annual Scientific Session 2017 suggest its greater efficacy in limiting aortic periprosthetic leaks [24]. It has to be noted that in none of the above-mentioned articles were the calcifications fully evaluated for their amount and structure by semi-automated methods. The quantitative morphometric analysis of the calcification distribution in the aortic complex proposed here may be more objective than semiquantitative methods proposed so far, and help to isolate the different patterns of the distribution and severity of calcifications. This was a preliminary, hypothesis-generating study. Its continuation in a prospectively planned study, with derivation and validation series, may contribute to the development of prospectively validated semi-automatic methods for the quantitative assessment of calcifications of the aortic complex. The results of the study may influence the results of the engineering work on the new valve models as well as subsequent clinical trials improving the efficacy and safety of procedures, especially in high-risk groups. The basic limitation of this project is the case-control design and small study and control group size. As mentioned above, however, it was a pilot study, aiming to assess the feasibility of the method before commencing a large prospective analysis.

Conclusions

Occurrence of paravalvular leak after TAVI is related to the size of calcification surface of the aortic complex. Quantitative assessment of aortic valve calcification volume, area and shape is feasible and yields clinically important information.

Conflict of interests

The authors declare no conflict of interest.
  22 in total

1.  Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients.

Authors:  Axel Unbehaun; Miralem Pasic; Stephan Dreysse; Thorsten Drews; Marian Kukucka; Alexander Mladenow; Ekaterina Ivanitskaja-Kühn; Roland Hetzer; Semih Buz
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

2.  Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis.

Authors:  Daniel John; Lutz Buellesfeld; Seyrani Yuecel; Ralf Mueller; Georg Latsios; Harald Beucher; Ulrich Gerckens; Eberhard Grube
Journal:  JACC Cardiovasc Interv       Date:  2010-02       Impact factor: 11.195

3.  Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement.

Authors:  Omar K Khalique; Rebecca T Hahn; Hemal Gada; Tamim M Nazif; Torsten P Vahl; Isaac George; Bindu Kalesan; Molly Forster; Mathew B Williams; Martin B Leon; Andrew J Einstein; Todd C Pulerwitz; Gregory D N Pearson; Susheel K Kodali
Journal:  JACC Cardiovasc Interv       Date:  2014-08       Impact factor: 11.195

4.  Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation.

Authors:  Martin Haensig; Lukas Lehmkuhl; Ardawan Julian Rastan; Joerg Kempfert; Chirojit Mukherjee; Matthias Gutberlet; David Michael Holzhey; Friedrich Wilhelm Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2012-01-12       Impact factor: 4.191

5.  Impact of post-dilatation on the reduction of paravalvular leak and mortality after transcatheter aortic valve implantation.

Authors:  Paweł Kleczyński; Artur Dziewierz; Marzena Daniec; Maciej Bagieński; Łukasz Rzeszutko; Danuta Sorysz; Jarosław Trębacz; Robert Sobczyński; Marek Tomala; Dariusz Dudek
Journal:  Kardiol Pol       Date:  2017       Impact factor: 3.108

6.  Aorta calcification burden: Towards an integrative predictor of cardiac outcome after transcatheter aortic valve implantation.

Authors:  Brahim Harbaoui; Mathieu Montoy; Paul Charles; Loic Boussel; Hervé Liebgott; Nicolas Girerd; Pierre-Yves Courand; Pierre Lantelme
Journal:  Atherosclerosis       Date:  2016-01-11       Impact factor: 5.162

7.  Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement.

Authors:  Marco Barbanti; Tae-Hyun Yang; Josep Rodès Cabau; Corrado Tamburino; David A Wood; Hasan Jilaihawi; Phillip Blanke; Raj R Makkar; Azeem Latib; Antonio Colombo; Giuseppe Tarantini; Rekha Raju; Ronald K Binder; Giang Nguyen; Melanie Freeman; Henrique B Ribeiro; Samir Kapadia; James Min; Gudrun Feuchtner; Ronen Gurtvich; Faisal Alqoofi; Marc Pelletier; Gian Paolo Ussia; Massimo Napodano; Fabio Sandoli de Brito; Susheel Kodali; Bjarne L Norgaard; Nicolaj C Hansson; Gregor Pache; Sergio J Canovas; Hongbin Zhang; Martin B Leon; John G Webb; Jonathon Leipsic
Journal:  Circulation       Date:  2013-06-07       Impact factor: 29.690

Review 8.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Authors:  A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2012-10-09       Impact factor: 24.094

9.  Role of multislice computed tomography in transcatheter aortic valve replacement.

Authors:  David A Wood; Laurens F Tops; John R Mayo; Sanjeevan Pasupati; Martin J Schalij; Karin Humphries; May Lee; Abdullah Al Ali; Brad Munt; Rob Moss; Christopher R Thompson; Jeroen J Bax; John G Webb
Journal:  Am J Cardiol       Date:  2009-05-01       Impact factor: 2.778

10.  Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry.

Authors:  Maciej Bagienski; Pawel Kleczynski; Artur Dziewierz; Lukasz Rzeszutko; Danuta Sorysz; Jaroslaw Trebacz; Robert Sobczynski; Marek Tomala; Maciej Stapor; Andrzej Gackowski; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-05-11       Impact factor: 1.426

View more
  2 in total

1.  Paravalvular leak prediction after transcatheter aortic valve replacement with self-expandable prosthesis based on quantitative aortic calcification analysis.

Authors:  Agata Wiktorowicz; Adrian Wit; Krzysztof Piotr Malinowski; Artur Dziewierz; Lukasz Rzeszutko; Dariusz Dudek; Pawel Kleczynski
Journal:  Quant Imaging Med Surg       Date:  2021-02

2.  Short-term safety and efficacy of transcarotid transcatheter aortic valve implantation with balloon-expandable vs. self-expandable valves.

Authors:  Damian Hudziak; Wojciech Wańha; Radosław Gocoł; Radosław Parma; Andrzej Ochała; Grzegorz Smolka; Joanna Ciosek; Tomasz Darocha; Marek A Deja; Wojciech Wojakowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.